GQ’s “Why Is Everyone On Steroids Now?” Interview with Author Rosecrans Baldwin

The discussion begins with a writer describing a feature story for a major magazine about steroid use. He explains that the idea grew from noticing gym friends quietly exploring testosterone and peptides for confidence. To report responsibly, he searched bodybuilding forums and found more than two dozen people willing to speak. Most sources insisted on anonymity, because openness still carries social and professional consequences. He says many users feel stereotyped by clichés, so they appreciated a portrayal beyond movie caricatures. The interviewer frames the conversation as harm reduction education rather than encouragement to start anabolics. Together they set a tone of curiosity, caution, and respect for lived experiences.

A vivid example centers on a young man who escalated from basic testosterone into heavier underground steroid use. He describes injecting into his chest as the only spot that still felt safe, which shocked the interviewer. What surprised the interviewer more was advice to pursue psychological therapy, not another hormonal shortcut. The source connects his earlier choices to deep insecurity and a body image fixation often called bigorexia. The conversation then broadens to social media, where extreme physiques are presented as pure training and diet. They note that high status celebrities may avoid admissions, while smaller influencers openly market drug routines for attention. That reward loop can make steroids feel like belonging to an online club, rather than a serious medical decision.

When the talk turns to consequences, they emphasize that stopping steroids can shut down natural hormone production. They warn that a teenager who starts early may later depend on testosterone long term to feel functional. The writer adds that young people rarely project decades ahead, even when fertility and cardiovascular risks are discussed. They debate whether broader harm reduction, and even limited legalization, will become necessary as usage spreads globally. The clinician argues that shame from healthcare workers keeps users from honest disclosure, which worsens safety outcomes. He recalls a hospital case involving heavy steroid exposure and a risky mix of Viagra and stimulants. The closing message is direct: avoid the slippery slope, because heart disease and kidney disease can follow later.